Related Experiment Video
Updated: Oct 9, 2025

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases
Published on: June 28, 2024
The Potentials of Methylene Blue as an Anti-Aging Drug
Huijing Xue1, Abhirami Thaivalappil1, Kan Cao1
1Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Abstract:
Methylene blue (MB), as the first fully man-made medicine, has a wide range of clinical applications. Apart from its well-known applications in surgical staining, malaria, and methemoglobinemia, the anti-oxidative properties of MB recently brought new attention to this century-old drug. Mitochondrial dysfunction has been observed in systematic aging that affects many different tissues, including the brain and skin. This leads to increaseding oxidative stress and results in downstream phenotypes under age-related conditions. MB can bypass Complex I/III activity in mitochondria and diminish oxidative stress to some degree. This review summarizes the recent studies on the applications of MB in treating age-related conditions, including neurodegeneration, memory loss, skin aging, and a premature aging disease, progeria.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Mitochondria
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

